When Lung Cancer Changes Identity: Study Maps the Immune Shift Behind Drug Resistance
A paired genomic and transcriptomic study of 32 patients shows that EGFR-mutant lung adenocarcinoma transforms into an immunosuppressed yet immunologically ...
A paired genomic and transcriptomic study of 32 patients shows that EGFR-mutant lung adenocarcinoma transforms into an immunosuppressed yet immunologically ...
A multi-omics study of 194 liver cancer patients shows that lenvatinib blood concentrations above 26.5 ng/mL predict treatment response, while ...
A comprehensive multi-omics study catalogues thousands of cancer-specific isoform switches in melanoma, ovarian cancer, and AML, showing that most disrupt ...
A five-year, $13.1 million NIH grant will fund engineered, nontoxic Salmonella designed to deliver radiopharmaceutical therapy, viral payloads, and immune-targeting ...
Researchers have functionally characterized CD34/CD123/CD25/CD99-positive leukemic progenitor cells in FLT3-ITD-mutated AML, showing they engraft and reinitiate leukemia in mice and ...
A longitudinal spatial multi-omics study reveals how the tumor microenvironment in EGFR-mutant lung cancer remodels in distinct stages as patients ...
Researchers have developed miRDrug, a machine-learning platform that integrates three biological databases to map the shared genes linking microRNAs, drugs ...
NIH has awarded its Director's Pioneer Award to Sylvester Comprehensive Cancer Center virologist Leor Weinberger for developing an evolving oncolytic ...
A new study links HDAC inhibitor treatment to remodeling of extrachromosomal circular DNA in ovarian cancer and identifies LMO2 as ...
A study of 152 Chinese children with acute lymphoblastic leukemia links mutations in the titin gene to prednisone resistance, poor ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine